FI956016A - 1,2-silloitettujen 1,4-dihydropyridiinien käyttö lääkeaineina - Google Patents

1,2-silloitettujen 1,4-dihydropyridiinien käyttö lääkeaineina Download PDF

Info

Publication number
FI956016A
FI956016A FI956016A FI956016A FI956016A FI 956016 A FI956016 A FI 956016A FI 956016 A FI956016 A FI 956016A FI 956016 A FI956016 A FI 956016A FI 956016 A FI956016 A FI 956016A
Authority
FI
Finland
Prior art keywords
dihydropyridines
bridged
drug
ch2ch2ch2
ch2ch
Prior art date
Application number
FI956016A
Other languages
English (en)
Swedish (sv)
Other versions
FI956016A0 (fi
Inventor
Klaus Urbahns
Hans-Georg Heine
Bodo Junge
Thomas Glaser
Reilinde Wittka
Vry Jean-Marie-Viktor De
Henning Sommermeyer
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI956016A0 publication Critical patent/FI956016A0/fi
Publication of FI956016A publication Critical patent/FI956016A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI956016A 1994-12-16 1995-12-14 1,2-silloitettujen 1,4-dihydropyridiinien käyttö lääkeaineina FI956016A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4444860A DE4444860A1 (de) 1994-12-16 1994-12-16 Verwendung von 1,2-überbrückten 1,4-Dihydropyridinen als Arzneimittel

Publications (2)

Publication Number Publication Date
FI956016A0 FI956016A0 (fi) 1995-12-14
FI956016A true FI956016A (fi) 1996-06-17

Family

ID=6535985

Family Applications (1)

Application Number Title Priority Date Filing Date
FI956016A FI956016A (fi) 1994-12-16 1995-12-14 1,2-silloitettujen 1,4-dihydropyridiinien käyttö lääkeaineina

Country Status (25)

Country Link
US (2) US5990121A (fi)
EP (2) EP0717043B1 (fi)
JP (1) JPH08239384A (fi)
KR (1) KR960022517A (fi)
CN (1) CN1059442C (fi)
AT (1) ATE186536T1 (fi)
AU (1) AU709760B2 (fi)
CA (1) CA2165131A1 (fi)
CZ (1) CZ332895A3 (fi)
DE (2) DE4444860A1 (fi)
DK (1) DK0717043T3 (fi)
EE (1) EE9500076A (fi)
ES (1) ES2139824T3 (fi)
FI (1) FI956016A (fi)
GR (1) GR3032394T3 (fi)
HU (1) HUT74166A (fi)
IL (1) IL116386A (fi)
MX (1) MX9505097A (fi)
NO (1) NO955103L (fi)
NZ (1) NZ280661A (fi)
PL (1) PL180439B1 (fi)
RU (1) RU2155765C2 (fi)
SI (1) SI0717043T1 (fi)
SK (1) SK158095A3 (fi)
ZA (1) ZA9510695B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050075359A1 (en) * 2003-03-14 2005-04-07 Rikako Kono Large conductance calcium-activated K channel opener
US7394475B2 (en) * 2004-02-13 2008-07-01 Infoprint Solutions Company, Llc Apparatus, system, and method for image registration
US20070203239A1 (en) * 2004-06-23 2007-08-30 Neurotec Pharma, S.L. Compounds For The Treatment Of An Acute Injury To The Central Nervous System
WO2006000607A1 (es) * 2004-06-23 2006-01-05 Neurotec Pharma, S.L. Uso de activadores de los canales de katp (kco), en particular el diazóxido, en el tratamiento de la inflamación crónica de snc asociada a algunas efermedades
CA2603676A1 (en) * 2005-01-07 2006-07-13 Roskamp Research Llc Compounds for inhibiting beta-amyloid production and methods of identifying the compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE220633C (fi) *
US4053614A (en) * 1972-03-06 1977-10-11 Bayer Aktiengesellschaft 1,2-pentamethylene-1,4-dihydropyridine derivatives
DE2210674C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2-Amino-6-methyl-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
US3951988A (en) * 1972-03-06 1976-04-20 Bayer Aktiengesellschaft 1,2-Pentamethylene-1,4-dihydropyridine derivatives
US3935220A (en) * 1972-03-06 1976-01-27 Bayer Aktiengesellschaft Tetrahydroimidazolo[1,2-a]pyridine derivatives
DE2210633C2 (de) * 1972-03-06 1983-09-22 Bayer Ag, 5090 Leverkusen Kondensierte Pyridinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5225566A (en) * 1992-05-08 1993-07-06 American Home Products Corporation Indazolanonyl derivative of benzopyran

Also Published As

Publication number Publication date
PL311843A1 (en) 1996-06-24
DK0717043T3 (da) 2000-05-08
EP0924211A2 (de) 1999-06-23
SI0717043T1 (en) 2000-02-29
AU4029495A (en) 1996-06-27
ES2139824T3 (es) 2000-02-16
ATE186536T1 (de) 1999-11-15
JPH08239384A (ja) 1996-09-17
NO955103L (no) 1996-06-17
EP0717043B1 (de) 1999-11-10
EE9500076A (et) 1996-06-17
IL116386A (en) 1999-06-20
HU9503597D0 (en) 1996-02-28
DE4444860A1 (de) 1996-06-20
GR3032394T3 (en) 2000-05-31
RU2155765C2 (ru) 2000-09-10
KR960022517A (ko) 1996-07-18
CA2165131A1 (en) 1996-06-17
DE59507220D1 (de) 1999-12-16
IL116386A0 (en) 1996-03-31
EP0717043A1 (de) 1996-06-19
EP0924211A3 (de) 1999-07-07
PL180439B1 (pl) 2001-02-28
NZ280661A (en) 1997-06-24
ZA9510695B (en) 1996-07-03
CZ332895A3 (en) 1997-12-17
SK158095A3 (en) 1996-09-04
AU709760B2 (en) 1999-09-09
FI956016A0 (fi) 1995-12-14
US5990121A (en) 1999-11-23
MX9505097A (es) 1997-01-31
NO955103D0 (no) 1995-12-15
HUT74166A (en) 1996-11-28
US6147087A (en) 2000-11-14
CN1133841A (zh) 1996-10-23
CN1059442C (zh) 2000-12-13

Similar Documents

Publication Publication Date Title
DE69013959D1 (de) Aminobenzolsulfonsäurederivate.
DE69434198D1 (de) Verfahren zur senkung des serumcholesterinspiegels mit 2,6-dialkyl-4 silyl-phenol derivaten
FI956016A (fi) 1,2-silloitettujen 1,4-dihydropyridiinien käyttö lääkeaineina
DK0737678T3 (da) 4-Indolylpiperazinyl-derivater
NZ329853A (en) 4-piperidinyl substituted 2-amino indane derivatives and medicaments
ATE229513T1 (de) Disubstituierte trans-3,4,4a,5,6,10b-hexahydro-2h-napht(1,2-b)- ,4-oxazine, verfahren zu deren herstellung und diese enthaltende pharmazeutigsche zusammensetzungen
ATE281452T1 (de) 4-amino-2-ureido-pyrimidin-5-carbonsäureamide, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
NO963374D0 (no) Substituerte 4H-pyraner
AU703092B2 (en) Benzene derivatives
HUP0002715A2 (hu) Benzotiofénszármazékok alkalmazása trombocitaszám csökkentésére szolgáló gyógyszerkészítmények előállítására
ATE195936T1 (de) Bis-imide derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitung
DE69837628D1 (de) Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
DE59606328D1 (de) Verfahren zur Herstellung von gegebenenfalls 2-substituierten 5-Chlor-imidazol-4-carbaldehyden
ATE194140T1 (de) Thiophenverbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zubereitungen
DE59712054D1 (de) 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung